ROIV insider files Form 144 to sell 1.6M shares

Frank M. Torti filed a Form 144 disclosing an intended sale of 1,600,000 shares of common stock of the issuer ROIV on 02/20/2026 tied to an exercise of stock options.

Rhea-AI Filing Summary

Frank M. Torti filed a Form 144 disclosing an intended sale of 1,600,000 shares of common stock of the issuer ROIV on 02/20/2026 tied to an exercise of stock options. The filing shows an aggregate value of $44,032,000 and identifies Morgan Stanley Smith Barney LLC as broker.

The filing also records prior 10b5-1 sales by Mr. Torti of 1,400,000 shares on 02/19/2026 with proceeds of $38,392,834.26. Transaction mechanics are shown as cash proceeds from option exercise.

Insights

Securities Transaction Analyst

Routine Form 144 records option exercise and a brokered sale of common shares.

The filing lists an intended disposal of 1,600,000 common shares on 02/20/2026 associated with an exercise of stock options, with an indicated aggregate amount of $44,032,000. A broker, Morgan Stanley Smith Barney LLC, is named for the transaction.

Prior 10b5-1 sales of 1,400,000 shares on 02/19/2026 produced $38,392,834.26. Timing and cash-flow mechanics are shown as cash from option exercise; subsequent filings will report completed trades and exact allocation of proceeds.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the ROIV Form 144 disclose?

The Form 144 discloses an intended sale of 1,600,000 shares tied to an exercise of stock options on 02/20/2026, with an aggregate amount of $44,032,000 and a named broker.

Who is listed as the broker for the ROIV sale?

Morgan Stanley Smith Barney LLC is named as the broker for the transaction, with the filing linking the sale date to 02/20/2026 and the method identified as cash from option exercise.

Has the filer recently sold other ROIV shares?

Yes. The Form 144 records prior 10b5-1 sales by Frank M. Torti of 1,400,000 shares on 02/19/2026, generating $38,392,834.26 in proceeds.

Does the Form 144 state how proceeds will be used?

The filing ties the transaction to an exercise of stock options and lists cash as the consideration, but it does not specify uses of proceeds in the disclosed lines of the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/20/2026 - 04:29 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001647805
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ROIVANT SCIENCES LTD
SEC File Number	001-40782
Address of Issuer	7th Floor 50 Broadway London UNITED KINGDOM SW1H 0DB
Phone	442074003347
Name of Person for Whose Account the Securities are To Be Sold	FRANK TORTI
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1600000	44032000.00	715701137	02/20/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/20/2026	Exercise of Stock Options	Issuer			1600000	02/20/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for FRANK M TORTI 7th Floor 50 Broadway London X0 SW1H 0DB	Common	02/19/2026	1400000	38392834.26

144: Remarks and Signature

Remarks
Date of Notice	02/20/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/20/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Frank Torti
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)